Publication Name	Artificial Intelligence in Cancer
Manuscript ID	66932
Country	China

Received	2021-04-10 01:02
Peer-Review Started	2021-04-10 01:02
To Make the First Decision
Return for Revision	2021-04-28 22:08
Revised	2021-05-11 07:33
Second Decision	2021-06-22 14:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-06-22 14:38
Articles in Press	2021-06-22 14:38
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-06-24 01:43
Typeset the Manuscript	2021-06-28 01:06
Publish the Manuscript Online	2021-06-28 09:42

ISSN	2644-3228 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Therapeutic tumor vaccines — a rising star to benefit cancer patients
Manuscript Source	Invited Manuscript
All Author List	Qian Wei, Zhao-Yuan Fang, Zi-Meng Zhang and Teng-Fei Zhang
Funding Agency and Grant Number
Corresponding Author	Teng-Fei Zhang, MD, Associate Professor, Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1 Eastern Jianshe Road, Zhengzhou 450052, Henan Province, China. fcczhangtf@zzu.edu.cn
Key Words	Tumor vaccines; Tumor cell vaccines; Dendritic cell vaccines; Peptide vaccines; Nucleic acid vaccines
Core Tip	There are many advancements in the field of cancer immunotherapy in the past decade such as the application of immune checkpoint blockade and adoptive cell therapy. Tumor therapeutic vaccines have emerged as an additional effective treatment strategy due to their ability to trigger potent immune response. Typically, they are tumor cell vaccines, dendritic cell vaccines, peptide vaccines or nucleic acid vaccines. This article mainly reviews the current clinical status as well as research and development status of these four types of therapeutic tumor vaccines for those who are interested.
Publish Date	2021-06-28 09:42
Citation	Wei Q, Fang ZY, Zhang ZM, Zhang TF. Therapeutic tumor vaccines — a rising star to benefit cancer patients. Artif Intell Cancer 2021; 2(3):25-41
URL	https://www.wjgnet.com/2644-3228/full/v2/i3/25.htm
DOI	https://dx.doi.org/10.35713/aic.v2.i3.25

Full Article (PDF)	AIC-2-25.pdf
Full Article (Word)	AIC-2-25.docx
Manuscript File	66932-Review-Filipodia.docx
Answering Reviewers	66932-Answering reviewers.pdf
Audio Core Tip	66932-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	66932-Conflict-of-interest statement.pdf
Copyright License Agreement	66932-Copyright license agreement.pdf
Peer-review Report	66932-Peer-review(s).pdf
Scientific Misconduct Check	66932-Bing-Ma YJ-1.jpg
Scientific Misconduct Check	66932-Bing-Fan JR-2.png
Scientific Misconduct Check	66932-Scientific misconduct check.pdf
Scientific Editor Work List	66932-Scientific editor work list.pdf